Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Consolidated Net Profit

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹3,486 Cr₹3,173 Cr₹1,928 Cr₹2,648 Cr₹5,335 Cr

What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?

The latest Consolidated Net Profit ratio of AUROBINDO PHARMA is ₹3,486 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹3,486 Cr
Mar2025₹3,173 Cr
Mar2024₹1,928 Cr
Mar2023₹2,648 Cr
Mar2022₹5,335 Cr

How is Consolidated Net Profit of AUROBINDO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹3,486 Cr
9.86
Mar2025 ₹3,173 Cr
64.62
Mar2024 ₹1,928 Cr
-27.21
Mar2023 ₹2,648 Cr
-50.36
Mar2022 ₹5,335 Cr -

Compare Consolidated Net Profit of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹97,012.4 Cr 1.8% 2.4% 60.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,339.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹254,068.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,767.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹111,804.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,113.4 Cr -0.8% -0.5% -9.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.8%

2.4%

60.2%

SENSEX

-1.8%

-3.7%

-5.7%


You may also like the below Video Courses